Search

Search bills, members, committees and pages...

H.R. 3152

U.S. HouseIn House Committee

Summary

H.R. 3152, the Patent Eligibility Restoration Act of 2025, was introduced in the House on May 1, 2025 by Rep. Kevin Kiley (I) with 1 co-sponsor. It was referred to Judiciary, and last saw action on May 1, 2025: Referred to the House Committee on the Judiciary.


Record

Text

H.R. 3152 has 1 co-sponsor.

hb3152/introduced-in-house.txt
119 HR 3152 IH: Patent Eligibility Restoration Act of 2025
U.S. House of Representatives
2025-05-01
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I
119th CONGRESS 1st Session
H. R. 3152
IN THE HOUSE OF REPRESENTATIVES
May 1, 2025
Mr. Kiley of California (for himself and Mr. Peters ) introduced the following bill; which was referred to the Committee on the Judiciary
A BILL
To amend title 35, United States Code, to address matters relating to patent subject matter eligibility, and for other purposes.
1.
Short title
This Act may be cited as the Patent Eligibility Restoration Act of 2025 .
2.
Findings
Congress finds the following:
(1)
As of the day before the date of enactment of this Act, patent eligibility jurisprudence interpreting section 101 of title 35, United States Code, requires significant modification and clarification.
(2)
For many years after the original enactment of section 101 of title 35, United States Code, the Supreme Court of the United States and other courts created judicial exceptions to the wording of that section, thereby rendering an increasing number of inventions ineligible for patent protection.
(3)
Efforts by judges of district courts and courts of appeals of the United States to apply the exceptions described in paragraph (2) to specific circumstances have led to extensive confusion and a lack of consistency—
(A)
throughout the judicial branch of the Federal Government and Federal agencies; and
(B)
among patent practitioners.
(4)
Many judges of the United States Court of Appeals for the Federal Circuit and of various district courts of the United States have explicitly expressed the need for more guidance with respect to the meaning of section 101 of title 35, United States Code, and many patent owners, and persons that engage with patent owners, complain that the interpretation of that section is extremely confusing and difficult to discern and apply with any confidence.
(5)
Under this Act, and the amendments made by this Act, the state of the law shall be as follows:
(A)
All judicial exceptions to patent eligibility are eliminated.
(B)
Any invention or discovery that can be claimed as a useful process, machine, manufacture, or composition of matter, or any useful improvement thereof, is eligible for patent protection, except as explicitly provided in section 101 of title 35, United States Code, as amended by this Act, as described in subparagraphs (D) and (E) of this paragraph.
(C)
Sections 102, 103, and 112 of title 35, United States Code, will continue to prescribe the requirements for obtaining a patent, but no such requirement will be used in determining patent eligibility.
(D)
The following inventions shall not be eligible for patent protection:
(i)
A mathematical formula that is not part of an invention that is in a category described in subparagraph (B).
(ii)
A mental process performed solely in the mind of a human being.
(iii)
An unmodified human gene, as that gene exists in the human body.
(iv)
An unmodified human gene that is isolated from the human body, but otherwise the same as that gene exists in the human body.
(v)
An unmodified natural material, as that material exists in nature.
(vi)
A process that is substantially economic, financial, business, social, cultural, or artistic.
(E)
Under the exception described in subparagraph (D)(vi)—
(i)
process claims drawn solely to the steps undertaken by human beings in methods of doing business, performing dance moves, offering marriage proposals, and the like shall not be eligible for patent coverage, and adding a non-essential reference to a computer by merely stating, for example, do it on a computer shall not establish such eligibility; and
(ii)
any process that cannot be practically performed without the use of a machine (including a computer) or manufacture shall be eligible for patent coverage.
3.
Patent eligibility
(a)
In general
Chapter 10 of title 35, United States Code, is amended—
(1)
in section 100—
(A)
in subsection (b), by striking includes a new use of a known process and inserting includes a use, application, or method of manufacture of a known or naturally-occurring process ; and
(B)
by adding at the end the following:
(k)
The term useful means, with respect to an invention or discovery, that the invention or discovery has a specific and practical utility from the perspective of a person of ordinary skill in the art to which the invention or discovery pertains.
; and
(2)
by amending section 101 to read as follows:
101.
Patent eligibility
(a)
In general
Whoever invents or discovers any useful process, machine, manufacture, or composition of matter, or any useful improvement thereof, may obtain a patent therefor, subject only to the exclusions in subsection (b) and to the further conditions and requirements of this title.
(b)
Eligibility exclusions
(1)
In general
Subject to paragraph (2), a person may not obtain a patent for any of the following, if claimed as such:
(A)
A mathematical formula that is not part of a claimed invention in a category described in subsection (a).
(B)
A process that is substantially economic, financial, business, social, cultural, or artistic, even though at least 1 step in the process refers to a machine or manufacture.
(C)
A process that—
(i)
is a mental process performed solely in the human mind; or
(ii)
occurs in nature wholly independent of, and prior to, any human activity.
(D)
An unmodified human gene, as that gene exists in the human body.
(E)
An unmodified natural material, as that material exists in nature.
(2)
Conditions
For the purposes of—
(A)
subparagraphs (A) and (B) of paragraph (1), the claimed invention shall not be excluded from eligibility for a patent if the invention cannot practically be performed without the use of a machine or manufacture;
(B)
paragraph (1)(D), a human gene shall not be considered to be unmodified if that human gene is—
(i)
purified, enriched, or otherwise altered by human activity; or
(ii)
otherwise employed in a useful invention or discovery; and
(C)
paragraph (1)(E), a natural material shall not be considered to be unmodified if that natural material is—
(i)
isolated, purified, enriched, or otherwise altered by human activity; or
(ii)
otherwise employed in a useful invention or discovery.
(c)
Eligibility
(1)
In general
In determining whether, under this section, a claimed invention is eligible for a patent, eligibility shall be determined—
(A)
by considering the claimed invention as a whole and without discounting or disregarding any claim element; and
(B)
without regard to—
(i)
the manner in which the claimed invention was made;
(ii)
whether a claim element is known, conventional, routine, or naturally occurring;
(iii)
the state of the applicable art, as of the date on which the claimed invention is invented; or
(iv)
any other consideration in section 102, 103, or 112.
(2)
Infringement action
(A)
In general
In an action brought for infringement under this title, the court, at any time, may determine whether an invention or discovery that is a subject of the action is eligible for a patent under this section, including on motion of a party when there are no genuine issues of material fact.
(B)
Limited discovery
With respect to a determination described in subparagraph (A), the court may consider limited discovery relevant only to the eligibility described in that subparagraph before ruling on a motion described in that subparagraph.
.
(b)
Technical and conforming amendment
The table of sections for chapter 10 of title 35, United States Code, is amended by striking the item relating to section 101 and inserting the following:
101. Patent eligibility.
.
4.
Rules of construction
(a)
Obviousness-Type double patenting
Nothing in this Act, or any amendment made by this Act, may be construed to affect or alter the judicially-created doctrine of obviousness-type double patenting.
(b)
Insignificant extra-Solution activity
With respect to the exclusions to patent eligibility described in subparagraphs (A) and (B) of section 101(b)(1) of title 35, United States Code, as added by section 3 of this Act, the inclusion of pre- or post-solution activity by a computer (or other machine or manufacture) in claim language shall not be sufficient to confer patent eligibility on the claim if that computer (or other machine or manufacture) is not necessary to practically perform the invention.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-05-01
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House May 1, 2025

hb3152/introduced-in-house.md

Shown Here:
Introduced in House (05/01/2025)

Sponsors

Rep. Kevin Kiley (I) sponsors H.R. 3152, and 1 member has co-sponsored it from the day it was introduced.

Committees

H.R. 3152 went before 1 committee: Judiciary.

Judiciary
Judiciary
Referred To · May 1, 2025 · 2,181 Bills

Actions

H.R. 3152 has taken 2 actions since May 1, 2025.

ChamberAction
May 1, 2025
House
Introduced in House
May 1, 2025
House
Referred to the House Committee on the Judiciary.Judiciary Committee

Votes

H.R. 3152 has not gone to a roll call.

1 bill is related to H.R. 3152, as Identical bill.

Titles

H.R. 3152 goes by 3 titles, 1 of them short titles.

  • To amend title 35, United States Code, to address matters relating to patent subject matter eligibility, and for other purposes. — Official Title as Introduced
  • Patent Eligibility Restoration Act of 2025 — Display Title
  • Patent Eligibility Restoration Act of 2025 — Short Title(s) as Introduced

Lobbying

36 clients hired 34 firms and 230 registered lobbyists who named H.R. 3152 in 137 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Copyright/Patent/Trademark, Trade (domestic/foreign), Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations, Health Issues, Labor Issues/Antitrust/Workplace, Computer Industry.

Clients

Who paid to be heard, by how many filings named the bill. The 20 that filed most often, of 36.

ClientBusinessStateFirmsFilingsReported
HIGH TECH INVENTORS ALLIANCECoalition advocating for policies to promote a balanced and pro-innovation patent systemDistrict of Columbia210$450K
NOVARTISDistrict of Columbia17
QUALCOMM INCORPORATEDDistrict of Columbia15$2.8M
COALITION FOR 21ST CENTURY PATENT REFORM15$490K
INNOVATION ALLIANCEInformal coalition interested in patent reformDistrict of Columbia15$400K
ASSOCIATION FOR MOLECULAR PATHOLOGYA medical subspecialty professional societyMaryland15$352.5K
UNITED FOR PATENT REFORMCoalition comprised of trade groups & companies concerned about weakening U.S. patent lawsDistrict of Columbia15$260K
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)Coalition to promote lowering prescription drug prices.District of Columbia15$250K
CISCO SYSTEMS INCIT, networking, and cybersecurity companyDistrict of Columbia15$250K
AUTMtrsde association for technology transfer/commercialization professionalsDistrict of Columbia15$100K
US INVENTORInventor Rights AdvocacyFlorida15$40K
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)LOBBYINGVirginia15
ASSOCIATION FOR ACCESSIBLE MEDICINESDistrict of Columbia15
GSK (FKA GLAXOSMITHKLINE INC.)District of Columbia15
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICADistrict of Columbia15
SOFTWARE & INFORMATION INDUSTRY ASSOCIATIONDistrict of Columbia15
THE CAMPAIGN FOR SUSTAINABLE RX PRICINGA coalition of organizations working on market-based solutions to drug pricing.District of Columbia14$360K
CONSERVATIVES FOR PROPERTY RIGHTSCoalitionSouth Carolina14$163K
3M COMPANYFederal Lobbying ActivityDistrict of Columbia14
AMAZON.COM SERVICES LLCDistrict of Columbia14

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 230.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2026 first_quarter$12.2M1st Quarter - Report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 third_quarter$9M3rd Quarter - Report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 fourth_quarter$8.4M4th Quarter - Report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2025 second_quarter$7.6M2nd Quarter - Report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2026 second_quarter$7.4M2nd Quarter - Report
AMAZON.COM SERVICES LLCAMAZON.COM SERVICES LLC2025 fourth_quarter$4.6M4th Quarter - Report
AMAZON.COM SERVICES LLCAMAZON.COM SERVICES LLC2026 first_quarter$4.4M1st Quarter - Report
AMAZON.COM SERVICES LLCAMAZON.COM SERVICES LLC2026 second_quarter$4.4M2nd Quarter - Report
AMAZON.COM SERVICES LLCAMAZON.COM SERVICES LLC2025 third_quarter$4.4M3rd Quarter - Report
NOVARTISNOVARTIS2026 first_quarter$3.9M1st Quarter - Report
AMGEN INCAMGEN, INC.2025 fourth_quarter$3.6M4th Quarter - Report
AMGEN INCAMGEN, INC.2025 third_quarter$3.6M3rd Quarter - Report
AMGEN INCAMGEN, INC.2026 first_quarter$2.6M1st Quarter - Report
AMGEN INCAMGEN, INC.2026 second_quarter$2.4M2nd Quarter - Report
BIOTECHNOLOGY INNOVATION ORGANIZATIONBIOTECHNOLOGY INNOVATION ORGANIZATION2026 second_quarter$2.4M2nd Quarter - Report
BAYER CORPORATION (CONSOLIDATED REPORT)BAYER CORPORATION (CONSOLIDATED REPORT)2026 second_quarter$1.8M2nd Quarter - Report
NOVARTISNOVARTIS2025 third_quarter$1.7M3rd Quarter - Amendme…
GSK (FKA GLAXOSMITHKLINE INC.)GSK (FKA GLAXOSMITHKLINE INC.)2025 third_quarter$1.7M3rd Quarter - Report
CATERPILLAR INCCATERPILLAR INC.2025 third_quarter$1.7M3rd Quarter - Report
CATERPILLAR INCCATERPILLAR INC.2026 first_quarter$1.7M1st Quarter - Report

Classification

The Congressional Research Service files H.R. 3152 under Commerce, one of its 31 policy areas, and gives it 3 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 3152’s is Commerce.

hr3152/policy-areas.txt
CommerceAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHealthHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 3152 carries 3 of CRS’s legislative subjects, from Intellectual property to Judicial review and appeals.

hr3152/subjects.txt
Intellectual propertyJudicial procedure and administrationJudicial review and appeals

Source: congress.gov · legiscan.com